Pfizer Inc. has five of the 27 Part B drugs subject to Medicare price inflation rebates for the first time under the Inflation Reduction Act, according to a list compiled by the Centers for Medicare and Medicaid Services.
Prices for Pfizer’s immunoglobulin Atgam, anti-bacterials Bicillin C-R and Bicillin L-A, anti-coagulant Fragmin and chemotherapy Nipent increased faster than the...







